This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.
More From The Market Online
![The Market Online Video](https://cdn.jwplayer.com/thumbs/NK94aTvW-720.jpg)
ASX Market Close: Banks lead Index to finish the week on a high | September 6, 2024
The bank stocks rallied leading the index higher, but Energy and mining stocks slumped in the…
- Sean Boss
- 2 mins
- 06 September 2024 18:01 (AEST)
![IPO concept](https://themarketonline.com.au/wp-content/uploads/2024/09/IPO-SEPT-scaled-e1725249650711-380x200.jpg)
Is the ASX getting its groove back? Here’s 5 IPOs in September to watch
After another slow year for IPOs on the ASX, September is looking like it could be…
- Jonathon Davidson
- 3 mins
- 02 September 2024 16:24 (AEST)
![Money is tight concept 2](https://themarketonline.com.au/wp-content/uploads/2024/09/wrap362--scaled-e1725606723751-380x200.jpg)
Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday
At the start of this week we saw NVIDIA – as a proxy for the AI…
- Jonathon Davidson
- 3 mins
- 06 September 2024 17:12 (AEST)
![The Market Online Video](https://cdn.jwplayer.com/thumbs/VQM0oCfs-720.jpg)
ASX Market Update: CBA breaks record as banks lead Index higher | September 6, 2024
Bank stocks have surged and dragged the market higher with the big 4 all outperforming and…
- Sean Boss
- 1 min
- 06 September 2024 13:47 (AEST)